Surgeon Simulator 2

Bossa Studios · 2021 · $19.99 · Action · deal grade B

Measured on 2026-09-26 04:19 UTC, 10 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

• Estimated net residual revenue: $1.5k to $2.2k per month
• Opportunity: $3.0k per month at x1.60 dormancy
• Estimated lifetime owners: 81.8k
• 42% positive across 2611 reviews · 14.9 reviews/month

Why it's flagged

• Developer silent for 4.3 years
• Studio active elsewhere (6 titles tracked), so this one may welcome a partner
• Last discounted 0 months ago, 10 sales in the last 12 months
• Proven demand elasticity: x1.3 review velocity during past deep sales

Analyst notes (AI-assisted)

Note written 2026-08-22; the live figures above take precedence over any numbers in it.

A physics-based surgical comedy game where players perform absurd operations on a patient using unconventional tools.

Surgeon Simulator 2 sits in a quiet pocket of the catalogue with low concurrent players (2 now, 6 peak 30d) but steady residual flow ($1.85k/mo mid-range) and a long median session length (4.65 hours). The 42.7% positive rate and 50+ month radio silence from developers suggest community frustration outweighs novelty appeal. For a publisher holding dormant comedy IP, the opportunity lies in targeted seasonal discounting (10 promotions in 12 months show elasticity sensitivity at 1.22) or licensing the surgical-mishap IP to mobile or streaming partners rather than pursuing live service revival. Most realistic play: licensing.

• Risk: Genre relies on novelty humor that degrades with age; 50+ months without dev communication suggests abandonment has eroded goodwill.
• Risk: Negative sentiment delta (-30 pts) and low recent positive rate (17.6%) indicate the community has cooled significantly since launch.
• Risk: Physics-based gameplay can suffer from engine rot; no cloud saves or workshop extensibility limits long-tail engagement.

This case as Markdown · Estimates carry ±30-50% error per title.